ERBB2 and neoplasm: The transduction efficiency of the UniCAR was identical to conventional CARs and in non-cellular activation assays and coculture experiments these UniCAR T cells were efficiently activated and induced specific anti-tumor responses in the presence of a HER2-recognizing linker and molecular or membrane-bound HER2 target.